What's in Sucampo Pharma Americas, LLC's pipeline?

Sucampo Pharma Americas, LLC has 3 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with Sucampo Pharma Americas, LLC's portfolio?

Top competitors by shared drug class: Brooke Army Medical Center, Henry Ford Health System.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/sucampo-pharma-americas-llc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Sucampo Pharma Americas, LLC — Portfolio Competitive Intelligence Brief

Sucampo Pharma Americas, LLC pipeline: 0 marketed, 0 filed, 2 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Cohort 1: Lubiprostone Capsule, Fasted	Cohort 1: Lubiprostone Capsule, Fasted	phase 3	Chloride channel activator	ClC-2 chloride channel	Gastroenterology
Lubiprostone 24	Lubiprostone 24	phase 3	ClC-2 chloride channel activator	ClC-2 chloride channel	Gastroenterology

Therapeutic area mix

Gastroenterology · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Brooke Army Medical Center · 1 shared drug class
Henry Ford Health System · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Sucampo Pharma Americas, LLC:

Cite this brief

Drug Landscape (2026). Sucampo Pharma Americas, LLC — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/sucampo-pharma-americas-llc. Accessed 2026-05-16.